Crossmark

Doxycycline-PEP — novel and promising but needs monitoring

Crossref DOI link: https://doi.org/10.1038/s41585-023-00788-1

Published Online: 2023-06-05

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Unemo, Magnus https://orcid.org/0000-0003-1710-2081
Kong, Fabian Yuh Shiong https://orcid.org/0000-0002-9349-3080
License Information

Text and Data Mining valid from 2023-06-05

Version of Record valid from 2023-06-05
More Information

Article History

First Online: 5 June 2023

Competing interests

: The authors declare no competing interests.